ALB and cancer: Mechanistic studies have demonstrated that an albumin-mediated nanoparticle formulation, rather than simple albumin-drug mixtures, is critical for achieving enhanced cellular uptake, providing compelling evidence that the nanoformulation process itself has therapeutic superiority in eliminating metastasis-driving cancer stem cells [82].